🇺🇸 FDA
Patent

US 9403815

Compounds and uses thereof in modulating levels of various amyloid beta peptide alloforms

granted A61PA61P25/00A61P25/14

Quick answer

US patent 9403815 (Compounds and uses thereof in modulating levels of various amyloid beta peptide alloforms) held by The Regents of the University of California expires Mon Jul 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Aug 02 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61P, A61P25/00, A61P25/14, A61P25/16, A61P25/28